Disease Info Card

Schizoaffective Disorder

Information about Schizoaffective Disorder: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Schizoaffective Disorder

Most recent studies have shown that Schizoaffective Disorder shares some biological mechanisms with affective-disorders-psychotic, anxiety-disorders, bipolar-disorder, cancer-patients-and-suicide-and-depression, chronic-schizophrenia, cognition-disorders, delusions, depressive-disorder, depressive-symptom, extrapyramidal-sign, hallucinations, major-depressive-disorder, manic, mental-disorders, mood-disorders, personality-disorders, psychotic-disorders, schizophrenia, schizophreniform-disorder, substance-related-disorders.

Among the many pathways, these few ones have gauged particular interests from scientists studying Schizoaffective Disorder, and have been seen in publications frequently: Aging, Brain Development, Cognition, Excretion, Immune Response, Localization, Pathogenesis, Prepulse Inhibition, Reflex, Response To Clozapine, Response To Methylphenidate, Response To Risperidone, Secretion, Sensory Processing, Serotonin Uptake, Social Behavior, Translation, Visual Learning, Visual Perception

Quite a number of genes have been found to play important roles in Schizoaffective Disorder, such as BDNF, COMT, CSF2, DIO2, DISC1, DRD2, FGF9, HTR2A, INS, LAMC2, NNT, NOS1, NOS2, PRL, RANGAP1, SKAP2, SLC17A5, SLC6A4, TRH, USH1G. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.